1887
Articles Open Access
Like 0
This item has no PDF Download

Abstract

In responding to our paper on the current limitations in influenza antiviral susceptibility testing in Europe, Ciancio and Nicoll criticise our suggestions for enhanced capacity in individual countries and favour a system that, as at present, relies on resistance monitoring by predefined central laboratories, as they consider this model most effective for clinical and public health purposes during a pandemic.

Loading

Article metrics loading...

/content/10.2807/esw.12.26.03228-en
2007-06-28
2017-11-21
http://instance.metastore.ingenta.com/content/10.2807/esw.12.26.03228-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurvweeklyarchive/12/26/art03228-en.htm?itemId=/content/10.2807/esw.12.26.03228-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error